Access and benefit-sharing by the European Virus Archive in response to COVID-19

Scarlett Sett; Carolina dos Santos Ribeiro; Christine Prat; George Haringhuizen; European Virus Archive principal investigators; Amber Hartman Scholz

doi:10.1016/S2666-5247(21)00211-1

Access and benefit-sharing by the European Virus Archive in response to COVID-19

Scarlett Sett, Carolina dos Santos Ribeiro, Christine Prat, George Haringhuizen, European Virus Archive principal investigators, Amber Hartman Scholz^*

^*Corresponding author for this work

Virology

Research output: Contribution to journal › Review article › Academic › peer-review

9 Citations (Scopus)

24 Downloads (Pure)

Abstract

Biobanking infrastructures, which are crucial for responding early to new viral outbreaks, share pathogen genetic resources in an affordable, safe, and impartial manner and can provide expertise to address access and benefit-sharing issues. The European Virus Archive has had a crucial role in the global response to the COVID-19 pandemic by distributing EU-subsidised (free of charge) viral resources to users worldwide, providing non-monetary benefit sharing, implementing access and benefit-sharing compliance, and raising access and benefit-sharing awareness among members and users. All currently available SARS-CoV-2 material in the European Virus Archive catalogue, including variants of concern, are not access and benefit-sharing cases per se, but multilateral benefit-sharing has nevertheless occurred. We propose and discuss how a multilateral system enabling access and benefit-sharing from pathogen genetic resources, based on the European Virus Archive operational model, could help bridge the discrepancies between the current bilateral legal framework for pathogen genetic resources and actual pandemic response practices.

Original language	English
Pages (from-to)	e316-e323
Journal	The Lancet Microbe
Volume	3
Issue number	4
DOIs	https://doi.org/10.1016/S2666-5247(21)00211-1
Publication status	Published - Apr 2022

Bibliographical note

Funding Information:
The manuscript was written by the European Virus Archive access and benefit-sharing compliance team but would not have been possible without the front-line scientists that built up the European Virus Archive infrastructure and have worked tirelessly over the past year to support the global pandemic response. We welcome the European Virus Archive signatory authors who endorse this publication and its call for a multilateral pathogen genetic resources mechanism tied to a distributed biobanking infrastructure. This publication was supported by the European Virus Archive-GLOBAL project that has received funding from the EU Horizon 2020 research and innovation programme (grant agreement number 871029).

Publisher Copyright:
© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2666-5247(21)00211-1Licence: Unspecified

Access and benefit-sharing by the European Virus Archive in response to COVID-19Final published version, 773 KBLicence: Unspecified

Cite this

@article{8af10a7be2b940339260eb82e2cc5802,

title = "Access and benefit-sharing by the European Virus Archive in response to COVID-19",

abstract = "Biobanking infrastructures, which are crucial for responding early to new viral outbreaks, share pathogen genetic resources in an affordable, safe, and impartial manner and can provide expertise to address access and benefit-sharing issues. The European Virus Archive has had a crucial role in the global response to the COVID-19 pandemic by distributing EU-subsidised (free of charge) viral resources to users worldwide, providing non-monetary benefit sharing, implementing access and benefit-sharing compliance, and raising access and benefit-sharing awareness among members and users. All currently available SARS-CoV-2 material in the European Virus Archive catalogue, including variants of concern, are not access and benefit-sharing cases per se, but multilateral benefit-sharing has nevertheless occurred. We propose and discuss how a multilateral system enabling access and benefit-sharing from pathogen genetic resources, based on the European Virus Archive operational model, could help bridge the discrepancies between the current bilateral legal framework for pathogen genetic resources and actual pandemic response practices.",

author = "Scarlett Sett and {dos Santos Ribeiro}, Carolina and Christine Prat and George Haringhuizen and {European Virus Archive principal investigators} and Tatjana Av{\v s}i{\v c} and Carrie Batten and Beato, {Maria Serena} and Herv{\'e} Bourhy and {Di Caro}, Antonino and R{\'e}mi Charrel and Bruno Coutard and Drexler, {Jan Felix} and Christian Drosten and Fooks, {Anthony R.} and Boris Klempa and Marion Koopmans and Thomas Klimkait and Stephan G{\"u}nther and Manuguerra, {Jean Claude} and Ali Mirazimi and Mettenleiter, {Thomas C.} and Florence Komurian-Pradel and Sven Reiche and Chantal Reusken and Romette, {Jean Louis} and {van der Werf}, Sylvie and David Williams and Scholz, {Amber Hartman}",

note = "Funding Information: The manuscript was written by the European Virus Archive access and benefit-sharing compliance team but would not have been possible without the front-line scientists that built up the European Virus Archive infrastructure and have worked tirelessly over the past year to support the global pandemic response. We welcome the European Virus Archive signatory authors who endorse this publication and its call for a multilateral pathogen genetic resources mechanism tied to a distributed biobanking infrastructure. This publication was supported by the European Virus Archive-GLOBAL project that has received funding from the EU Horizon 2020 research and innovation programme (grant agreement number 871029). Publisher Copyright: {\textcopyright} 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license",

year = "2022",

month = apr,

doi = "10.1016/S2666-5247(21)00211-1",

language = "English",

volume = "3",

pages = "e316--e323",

journal = "The Lancet Microbe",

issn = "2666-5247",

publisher = "Elsevier Ltd.",

number = "4",

}

TY - JOUR

T1 - Access and benefit-sharing by the European Virus Archive in response to COVID-19

AU - Sett, Scarlett

AU - dos Santos Ribeiro, Carolina

AU - Prat, Christine

AU - Haringhuizen, George

AU - European Virus Archive principal investigators

AU - Avšič, Tatjana

AU - Batten, Carrie

AU - Beato, Maria Serena

AU - Bourhy, Hervé

AU - Di Caro, Antonino

AU - Charrel, Rémi

AU - Coutard, Bruno

AU - Drexler, Jan Felix

AU - Drosten, Christian

AU - Fooks, Anthony R.

AU - Klempa, Boris

AU - Koopmans, Marion

AU - Klimkait, Thomas

AU - Günther, Stephan

AU - Manuguerra, Jean Claude

AU - Mirazimi, Ali

AU - Mettenleiter, Thomas C.

AU - Komurian-Pradel, Florence

AU - Reiche, Sven

AU - Reusken, Chantal

AU - Romette, Jean Louis

AU - van der Werf, Sylvie

AU - Williams, David

AU - Scholz, Amber Hartman

N1 - Funding Information: The manuscript was written by the European Virus Archive access and benefit-sharing compliance team but would not have been possible without the front-line scientists that built up the European Virus Archive infrastructure and have worked tirelessly over the past year to support the global pandemic response. We welcome the European Virus Archive signatory authors who endorse this publication and its call for a multilateral pathogen genetic resources mechanism tied to a distributed biobanking infrastructure. This publication was supported by the European Virus Archive-GLOBAL project that has received funding from the EU Horizon 2020 research and innovation programme (grant agreement number 871029). Publisher Copyright: © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license

PY - 2022/4

Y1 - 2022/4

N2 - Biobanking infrastructures, which are crucial for responding early to new viral outbreaks, share pathogen genetic resources in an affordable, safe, and impartial manner and can provide expertise to address access and benefit-sharing issues. The European Virus Archive has had a crucial role in the global response to the COVID-19 pandemic by distributing EU-subsidised (free of charge) viral resources to users worldwide, providing non-monetary benefit sharing, implementing access and benefit-sharing compliance, and raising access and benefit-sharing awareness among members and users. All currently available SARS-CoV-2 material in the European Virus Archive catalogue, including variants of concern, are not access and benefit-sharing cases per se, but multilateral benefit-sharing has nevertheless occurred. We propose and discuss how a multilateral system enabling access and benefit-sharing from pathogen genetic resources, based on the European Virus Archive operational model, could help bridge the discrepancies between the current bilateral legal framework for pathogen genetic resources and actual pandemic response practices.

AB - Biobanking infrastructures, which are crucial for responding early to new viral outbreaks, share pathogen genetic resources in an affordable, safe, and impartial manner and can provide expertise to address access and benefit-sharing issues. The European Virus Archive has had a crucial role in the global response to the COVID-19 pandemic by distributing EU-subsidised (free of charge) viral resources to users worldwide, providing non-monetary benefit sharing, implementing access and benefit-sharing compliance, and raising access and benefit-sharing awareness among members and users. All currently available SARS-CoV-2 material in the European Virus Archive catalogue, including variants of concern, are not access and benefit-sharing cases per se, but multilateral benefit-sharing has nevertheless occurred. We propose and discuss how a multilateral system enabling access and benefit-sharing from pathogen genetic resources, based on the European Virus Archive operational model, could help bridge the discrepancies between the current bilateral legal framework for pathogen genetic resources and actual pandemic response practices.

UR - http://www.scopus.com/inward/record.url?scp=85120910331&partnerID=8YFLogxK

U2 - 10.1016/S2666-5247(21)00211-1

DO - 10.1016/S2666-5247(21)00211-1

M3 - Review article

C2 - 34806057

AN - SCOPUS:85120910331

SN - 2666-5247

VL - 3

SP - e316-e323

JO - The Lancet Microbe

JF - The Lancet Microbe

IS - 4

ER -

Access and benefit-sharing by the European Virus Archive in response to COVID-19

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this